The EMA CHMP has recommended granting approval for AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis ...

Takeda has secured the Japanese MHLW approval for its FRUZAQLA to treat unresectable advanced or recurrent colorectal cancer ...

The EC has granted marketing authorisation to LEO Pharma’s Anzupgo cream for treating adults with moderate to severe chronic ...

UCB has received US FDA approval for BIMZELX (bimekizumab-bkzx) to treat adults with three inflammatory conditions.

According to GlobalData’s company profile on Telesis Bio, was a key innovation area identified from patents. Telesis Bio's grant share as of July 2024 was 62%. Grant share is based on the ratio of ...

Discover Vivos Therapeutics' patented oral appliance designed to enhance jaw development and alleviate sleep disorders with adjustable features for optimal comfort and effectiveness.

Discover Laurus Labs' groundbreaking patent for an innovative dapagliflozin synthesis process, enhancing diabetes treatment with novel intermediates and formulations.

Discover Lyell Immunopharma's groundbreaking patent for EGFR-derived polypeptides, enhancing cancer treatment through innovative nucleic acid technologies and engineered T cells.

Discover Agile Therapeutics' patented transdermal drug delivery device, designed to reduce skin irritation and enhance stability for effective seven-day wear.

The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

The European Commission (EC) has conditionally approved Ipsen ’s Iqirvo (elafibranor) for the treatment of primary biliary ...

Pancreatic cancer is resistant to conventional therapies, but cutting-edge research may improve survival rates and patient ...